Cost-effectiveness of an exercise program during pregnancy to prevent gestational diabetes: Results of an economic evaluation alongside a randomised controlled trial

BMC Pregnancy and Childbirth

Mireille NM van Poppel⁴  Willem van Mechelen³  Elisabeth MW Eekhoff¹  Maurice GAJ Wouters⁵  Judith Bosmans⁶  Nicolette Oostdam² 

[1] Department of Endocrinology, VU University Medical Center, Amsterdam, the Netherlands;Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands;Body@Work, Research Center Physical Activity, Work and Health, TNO-VU University Medical Center, Amsterdam and Hoofddorp, the Netherlands;Department of Public and Occupational Health, VU University Medical Center, Van der Boechorststraat 7, Room-C568, 1081 BT, Amsterdam, the Netherlands;Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, the Netherlands;Department of Health Sciences and EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, Amsterdam, the Netherlands

关键词: Exercise;    Pregnancy;    Cost-effectiveness;   

Others  :  1152641
DOI  :  10.1186/1471-2393-12-64

 received in 2012-02-16, accepted in 2012-07-04,  发布年份 2012

【 摘 要 】

Background

The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide. GDM and the risks associated with GDM lead to increased health care costs and losses in productivity. The objective of this study is to evaluate whether the FitFor2 exercise program during pregnancy is cost-effective from a societal perspective as compared to standard care.

Methods

A randomised controlled trial (RCT) and simultaneous economic evaluation of the FitFor2 program were conducted. Pregnant women at risk for GDM were randomised to an exercise program to prevent high maternal blood glucose (n = 62) or to standard care (n = 59). The exercise program consisted of two sessions of aerobic and strengthening exercises per week. Clinical outcome measures were maternal fasting blood glucose levels, insulin sensitivity and infant birth weight. Quality of life was measured using the EuroQol 5-D and quality-adjusted life-years (QALYs) were calculated. Resource utilization and sick leave data were collected by questionnaires. Data were analysed according to the intention-to-treat principle. Missing data were imputed using multiple imputations. Bootstrapping techniques estimated the uncertainty surrounding the cost differences and incremental cost-effectiveness ratios.

Results

There were no statistically significant differences in any outcome measure. During pregnancy, total health care costs and costs of productivity losses were statistically non-significant (mean difference €1308; 95%CI €-229 - €3204). The cost-effectiveness analyses showed that the exercise program was not cost-effective in comparison to the control group for blood glucose levels, insulin sensitivity, infant birth weight or QALYs.

Conclusion

The twice-weekly exercise program for pregnant women at risk for GDM evaluated in the present study was not cost-effective compared to standard care. Based on these results, implementation of this exercise program for the prevention of GDM cannot be recommended.

Trial registration

NTR1139

【 授权许可】

   
2012 Oostdam et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ferrara A: Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007, 30(Suppl 2):S141-S146.
• [2]Cheung NW: The management of gestational diabetes. Vasc Health Risk Manag 2009, 5:153-164.
• [3]Gestational diabetes mellitus Diabetes Care 2004, 27(Suppl 1):S88-S90.
• [4]Dempsey JC, Butler CL, Sorensen TK, Lee IM, Thompson ML, Miller RS, Frederick IO, Williams MA: A case–control study of maternal recreational physical activity and risk of gestational diabetes mellitus. Diabetes Res Clin Pract 2004, 66:203-215.
• [5]Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, et al.: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
• [6]Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, Moore V, Sahai N, Dall TM: Cost of gestational diabetes mellitus in the United States in 2007. Popul Health Manag 2009, 12:165-174.
• [7]Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J: The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26:3230-3236.
• [8]The prevention or delay of type 2 diabetes Diabetes Care 2002, 25:742-749.
• [9]Reimann M, Bonifacio E, Solimena M, Schwarz PE, Ludwig B, Hanefeld M, Bornstein SR: An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Ther 2009, 121:317-331.
• [10]Oostdam N, van Poppel MN, Wouters MG, van Mechelen MW: Interventions for preventing gestational diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt) 2011, 20:1551-1563.
• [11]Oostdam N, van Poppel MN, Eekhoff MGAJ, Bekedam DJ, Kuchenbecker WKH, Quartero HWP, Heres MHB, van Mechelen W: No effect of the FitFor2 exercise program on blood glucose, insulin sensitivity, and birth weight in overweight pregnant women at risk for gestational diabetes: results of a randomised controlled trial. BJOG 2012.
• [12]Oostdam N, van Poppel MN, Eekhoff EM, Wouters MG, van Mechelen MW: Design of FitFor2 study: the effects of an exercise program on insulin sensitivity and plasma glucose levels in pregnant women at high risk for gestational diabetes. BMC Pregnancy Childbirth 2009, 9:1. BioMed Central Full Text
• [13]EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group Health Policy 1990, 16:199-208.
• [14]Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ: Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 2005, 149:1574-1578.
• [15]Hakkaart-van Roijen L, Tan SS, Bouwmans CAM: Handleiding voor kostenonderzoek. CVZ College Voor Zorgverzekeringen, Diemen; 2010.
• [16]Z-index. G-Standard. The Hague, The Netherlands, Z-Index BV; 2006.
• [17]van Buuren S: Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007, 16:219-242.
• [18]Rubin DB: Multiple Imputation for Nonresponse in Surveys. J Wiley & Sons, New York; 1987.
• [19]Burton A, Billingham LJ, Bryan S: Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clin Trials 2007, 4:154-161.
• [20]Black WC: The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990, 10:212-214.
• [21]Fenwick E, O'Brien BJ, Briggs A: Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ 2004, 13:405-415.
• [22]Kolu P, Raitanen J, Luoto R: Cost of gestational diabetes-related antenatal visits in health care based on the Finnish Medical Birth Register. Prim Care Diabetes 2011, 5:139-141.
• [23]Galtier-Dereure F, Montpeyroux F, Boulot P, Bringer J, Jaffiol C: Weight excess before pregnancy: complications and cost. Int J Obes Relat Metab Disord 1995, 19:443-448.
• [24]Galtier-Dereure F, Boegner C, Bringer J: Obesity and pregnancy: complications and cost. Am J Clin Nutr 2000, 71:1242S-1248S.
• [25]Briggs A: Economic evaluation and clinical trials: size matters. BMJ 2000, 321:1362-1363.
• [26]van den Brink M, van den Hout WB, Stiggelbout AM, Putter H, van de Velde CJ, Kievit J: Self-reports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care 2005, 21:298-304.